Tag: FDA

Proving bioequivalence for complex generic drugs-like inhalers, topical creams, and injectables-is far harder than for simple pills. Learn why these life-saving generics are still rare and what’s being done to change that.

Proving bioequivalence for complex generics like inhalers, creams, and injections is far harder than for regular pills. Learn why these life-saving drugs are so rare-and what’s being done to change that.